US Stock Market Closed

Dashboard

NeuroBo Pharmaceuticals, Inc. (NRBO)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity
Analyst Opinion

H

Leverage & Liquidity

H

Fundamental Variables

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.

CEO

Jeong Gu Kang

Employees

12

Industry

-

Sector

-

Headquarters

Boston

Exchange

NASDAQ

Website

-

Summary Stats

Market Cap

6.34M

Revenue

-

Net Income

-

EPS

$0.00

Price-to-Earnings

-

Price-to-Book

-

Debt-to-Equity

-

News

Analyst Ratings

Price targets projected by 1 analyst

High

$20.00

Average

$20.00

Low

$20.00

Ratings calculated by 1 analyst

Buy

1

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Not Available

Actual

-$3.50 -

Consensus

-

Report Date

Year Ago

-0.16

Year Ago Change %

Down 2087%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites